|
Index of reports
> Cases with Blood Bilirubin Increased (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abelcet (Amphotericin B) where reactions include blood bilirubin increased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Abelcet side effects in 74 year old female
Reported by a individual with unspecified qualification from United States on 2011-12-27
Patient: 74 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Blood Bilirubin Increased, Renal Impairment, Laboratory Test Interference, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Abelcet
Dosage: 335 mg, qd, iv
Indication: Systemic Mycosis
Start date: 1996-12-03
End date: 1996-12-10
Amphotericin B
Dosage: 40 mg, qd, iv
Indication: Systemic Mycosis
Start date: 1996-11-28
End date: 1996-12-01
Other drugs received by patient: Gentamicin; Vancomycin; Cytarabine; Mitoxantrone; Etoposide; Ciprofloxacin; Immunoglobulin Human Normal; Aztreonam
Possible Abelcet side effects in 56 year old male
Reported by a physician from United States on 2011-12-27
Patient: 56 year old male
Reactions: Multi-Organ Failure, Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Renal Failure, Aspartate Aminotransferase Increased, Acute Respiratory Distress Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abelcet
Possible Abelcet side effects in female
Reported by a physician from United States on 2011-11-15
Patient: female, weighing 57.5 kg (126.5 pounds)
Reactions: Blood Bilirubin Increased, Chest Discomfort, Dyspnoea, Wheezing, Blood Albumin Decreased, Drug Interaction, Pyrexia, Renal Impairment, Oedema Peripheral, Hypoxia, Aspergillosis, Pulmonary Oedema, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abelcet
Gleevec
Dosage: 400 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2004-03-14
End date: 2004-03-23
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Other drugs received by patient possibly interacting with the suspect drug:
Voriconazole
Other drugs received by patient: Hydrea; Acyclovir; Vancomycin; Oxycodone HCL; Zosyn; Gentamicin
|
